RSH Stock Overview
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia.
Notes are coming soon
Respiri Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.05|
|52 Week High||AU$0.069|
|52 Week Low||AU$0.032|
|1 Month Change||8.70%|
|3 Month Change||35.14%|
|1 Year Change||-3.85%|
|3 Year Change||-41.18%|
|5 Year Change||-28.57%|
|Change since IPO||-95.69%|
Recent News & Updates
We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn RateAug 17
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn SituationApr 29
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn SituationJan 03
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn SituationSep 21
We Think Respiri (ASX:RSH) Can Afford To Drive Business GrowthJun 07
Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth PlansFeb 22
|RSH||AU Medical Equipment||AU Market|
Return vs Industry: RSH underperformed the Australian Medical Equipment industry which returned 5.3% over the past year.
Return vs Market: RSH underperformed the Australian Market which returned 2.1% over the past year.
|RSH Average Weekly Movement||12.6%|
|Medical Equipment Industry Average Movement||10.1%|
|Market Average Movement||8.5%|
|10% most volatile stocks in AU Market||15.5%|
|10% least volatile stocks in AU Market||3.4%|
Stable Share Price: RSH is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: RSH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal.
Respiri Limited Fundamentals Summary
|RSH fundamental statistics|
Is RSH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RSH income statement (TTM)|
|Cost of Revenue||AU$259.29k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.0082|
|Net Profit Margin||-857.85%|
How did RSH perform over the long term?See historical performance and comparison